1 / of 4

F300 smartwatch ECG electrocardiogram monitoring SOS fall alarm blood glucose and blood pressure watch HRV report

VSF Vyvata Standard How we score →

20 / 100

Rejected

Cardiac ecg

Evidence
Safety
Formulation
Transparency
Sustainability
Manufacturing

⚠ Why this product was auto-rejected

The F300 is a generic Shenzhen white-label smartwatch sold under dozens of marketplace names that claims FDA-equivalent clinical functions — ECG, AFib-grade rhythm analysis, non-invasive blood glucose, and blood pressure — at $73 with no listed FDA 510(k) clearance for any of these features. Non-invasive blood-glucose monitoring is not yet a validated technology at any price; the FDA and credible reviews (GoodRx, peer-reviewed literature) confirm no smartwatch is FDA-authorized for glucose measurement as of 2026. Marketing all four regulated functions without clearance is a clear unverified_medical_claim and a meaningful patient-safety risk.

Scoring rubric for F300 smartwatch ECG electrocardiogram monitoring SOS fall alarm blood glucose and blood pressure watch HRV report

Overall VSF 20/100Tier RejectedLast scored June 30, 2026

Evidence 10

What we scored Rejected under unverified_medical_claim. The listing claims ECG, rhythm analysis, non-invasive blood glucose and blood pressure measurement with no FDA 510(k) clearance for any of these features, and non-invasive glucose monitoring is not a validated technology in any smartwatch as of 2026.

What was missing FDA clearance and published accuracy validation for each claimed clinical measurement, or removal of the unvalidated glucose and blood-pressure claims, would raise this dimension.

Formulation 25

What we scored The title lists ECG, SOS fall alarm, blood glucose, blood pressure and HRV reporting; no sensor hardware, sampling rate or algorithm methodology is disclosed.

What was missing A published spec sheet covering sensor types, sampling rates, algorithm methods and battery life, limited to functions the hardware can actually measure, would raise Formulation.

Manufacturing 25

What we scored The F300 is a generic white-label smartwatch sold under many marketplace names, with no identifiable manufacturer, registration or warranty on the record.

What was missing An identified manufacturer with FDA registration for any medical functions, FCC/CE registration and warranty terms would raise this dimension.

Safety 20

What we scored Marketing blood-glucose and blood-pressure readings that are not validated is a meaningful patient-safety risk: users managing diabetes or hypertension could act on inaccurate numbers.

What was missing Removing or clearing the glucose and blood-pressure claims, and publishing clear 'not a medical device' limitations, would raise Safety.

Transparency 20

What we scored The listing presents four regulated clinical functions without disclosing that none are cleared, which is the core transparency failure.

What was missing Honest disclosure of regulatory status per feature and public accuracy specs would raise Transparency.

Sustainability 35

What we scored No packaging, repairability, battery-replacement or e-waste disclosure is stored for this powered device, so the Sustainability score reflects the neutral default applied when there is no data.

What was missing Published battery-replacement or repair options, an e-waste or take-back program, and packaging-material disclosure would raise this dimension.

Full methodology

Compare similar products

No reviews

Regular price $73.54 USD

Regular price Sale price $73.54 USD

Sale Sold out

Shipping calculated at checkout.

color Black siliconeVariant sold out or unavailable Black powder glueVariant sold out or unavailable Black gray glueVariant sold out or unavailable Black MilanVariant sold out or unavailable Black three plantsVariant sold out or unavailable black skinVariant sold out or unavailable Black brown skinVariant sold out or unavailable

Quantity Quantity

(0 in cart)

The full picture

Score, six-dimension breakdown, evidence, and FAQ. Every vendor is scored on the same published rubric — no brand can pay for placement. Read the rubric →

Analysis Evidence FAQ

20/100

Rejected

Six-dimension breakdown

Evidence

Formulation

Manufacturing

Safety

Transparency

Sustainability

Last scored: June 30, 2026Full rubric →

Evidence & sources

The Vyvata score's Evidence dimension measures the quality of published RCT support for a product's active ingredients at the label dose. Our source hierarchy: double-blind RCTs in MEDLINE-indexed journals > single-blind RCTs > open-label trials > observational studies > mechanism papers > N=1 case studies (anecdotes). Predatory journals and manufacturer-authored studies without independent replication are weighted down.

Cited for this product

fitnessvibesuk.com/products/f300-smartwatch-ecg-electrocardiogram-monitoring-sos-fall-alarm-blood...
www.goodrx.com/conditions/diabetes/blood-glucose-smartwatches
www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm

How to read the Evidence dimension

80–100: Multiple double-blind RCTs in indexed journals directly testing this product OR the exact ingredients at the exact dose.
60–79: Single double-blind RCT + supporting ingredient literature at the studied dose.
40–59: Open-label trials + ingredient literature; no product-specific double-blind evidence.
20–39: Ingredient literature only; no product-specific trials or trials in predatory venues.
0–19: No credible evidence base or unverifiable claims.

Frequently asked questions

Auto-generated from Vyvata's scoring data for this product. For general questions about the store (shipping, returns, wholesale), see the site FAQ.

What is F300 smartwatch ECG electrocardiogram monitoring SOS fall alarm blood glucose and blood pressure watch HRV report?

F300 smartwatch ECG electrocardiogram monitoring SOS fall alarm blood glucose and blood pressure watch HRV report is a product from V.I.P Digital Presence, categorized under Cardiac & ECG monitors in the Wearables & Tracking vertical. It is scored on the Vyvata Scoring Framework — an independent 6-dimension rubric applied uniformly to every product Vyvata lists.

How does F300 smartwatch ECG electrocardiogram monitoring SOS fall alarm blood glucose and blood pressure watch HRV report score on the Vyvata rubric?

20/100 overall — Rejected tier (0–49 band). Per-dimension breakdown: Sustainability 35, Formulation 25, Manufacturing 25, Safety 20, Transparency 20, Evidence 10. Scored as of 2026-08-24.

Why did F300 smartwatch ECG electrocardiogram monitoring SOS fall alarm blood glucose and blood pressure watch HRV report score in the Rejected tier?

What are the strongest and weakest aspects of this product?

Strongest: Sustainability at 35 (sourcing practices, packaging, and corporate practice) and Formulation at 25 (dose adequacy, bioavailability form, and ingredient redundancy). Weakest: Transparency at 20 (dose disclosure vs proprietary blends, and honesty of marketing claims) and Evidence at 10 (quality of published RCT support for the active ingredients at the label dose). All six dimensions feed the overall Vyvata score; a weakness on any one dimension pulls the overall down proportionally.

Is F300 smartwatch ECG electrocardiogram monitoring SOS fall alarm blood glucose and blood pressure watch HRV report third-party tested?

No third-party certifications (NSF, USP, ConsumerLab, or equivalent) were on record at the time of scoring. This affects the Manufacturing dimension score. The manufacturer may test internally or have obtained certification more recently — check the current product label for the most up-to-date information.

Why was this product auto-rejected?

This product triggered the Vyvata auto-fail rule "unverified_medical_claim", which places it in the Rejected tier regardless of its scores on other dimensions. See the full explanation above and the methodology page for the current list of auto-fail rules.

What does the Vyvata score mean?

The Vyvata Scoring Framework rates every listed product 0–100 across six dimensions: Evidence, Formulation, Manufacturing, Safety, Transparency, and Sustainability. Tier bands: Elite 85–100 (top-tier evidence + formulation + manufacturing), Verified 70–84 (strong on most dimensions), Standard 50–69 (solid but with weaknesses called out), Rejected 0–49 (specific failures documented). Rejected products remain listed with reasons. Full methodology at https://vyvata.com/pages/methodology.

Where can I read customer reviews for F300 smartwatch ECG electrocardiogram monitoring SOS fall alarm blood glucose and blood pressure watch HRV report?

The Vyvata score measures product integrity against a published rubric, not customer sentiment. For customer reviews and community discussion, search external platforms directly: Amazon (https://www.amazon.com/s?k=V.I.P%20Digital%20Presence%20F300%20smartwatch%20ECG%20electrocardiogram%20monitoring%20SOS%20fall%20alarm%20blood%20glucose%20and%20blood%20pressure%20),Google(https://www.google.com/search?q=V.I.P%20Digital%20Presence%20F300%20smartwatch%20ECG%20electrocardiogram%20monitoring%20SOS%20fall%20alarm%20blood%20glucose%20and%20blood%20pressure%20+reviews),Reddit(https://www.reddit.com/search/?q=V.I.P%20Digital%20Presence%20F300%20smartwatch%20ECG%20electrocardiogram%20monitoring%20SOS%20fall%20alarm%20blood%20glucose%20and%20blood%20pressure%20%20review),andTrustpilot(https://www.trustpilot.com/search?query=V.I.P%20Digital%20Presence%20F300%20smartwatch%20ECG%20electrocardiogram%20monitoring%20SOS%20fall%20alarm%20blood%20glucose%20and%20blood%20pressure%20).Vyvatadoesnotaggregate,republish,orlicensethosethird-partyreviews.